Carrefour : Good timing to go long again
Entry price | Target | Stop-loss | Potential |
---|
€16.3 |
€17.25 |
€15.75 |
+5.86% |
---|
The selling pressure regarding Carrefour shares could subside shortly. In fact, the support area that is currently being tested around 16.16 EUR has come into play and could, at least in the short term, keep the downside pressure at bay.
Summary● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company presents an interesting fundamental situation from a short-term investment perspective.
● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths● The company's attractive earnings multiples are brought to light by a P/E ratio at 11.37 for the current year.
● The company shows low valuation levels, with an enterprise value at 0.24 times its sales.
● The company's share price in relation to its net book value makes it look relatively cheap.
● The group usually releases upbeat results with huge surprise rates.
Weaknesses● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● Low profitability weakens the company.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.